期刊文献+

隆突性皮肤纤维肉瘤21例临床分析 被引量:7

Clinical Analysis of 21 Patients of Dermatofibrosacoma Protuberans
下载PDF
导出
摘要 目的分析隆突性皮肤纤维肉瘤的临床特征,探讨其治疗方法。方法回顾性分析该21例患者的临床表现,误诊情况,病理表现,影像学(包括胸片、彩超、MRI)及治疗和转归等资料,进行描述性分析。结果 21例隆突性皮肤纤维肉瘤患者中男9例,女12例;初诊误诊13例(61.90%),21例均以扩大3cm进行手术切除,术后放疗,随访1~5年,复发2例;结论隆突性皮肤纤维肉瘤以单一红色结节为原发皮损,容易误诊,不易发生转移,行扩大切除术+辅助放疗是治疗隆突性皮肤纤维肉瘤的主要治疗方法。 Objective To analyze the clinical features and treatment of dermatofibrosarcoma protuberans. Methods The clinical manifestations, misdiagnosis, pathological features, imaging(including chest radiography, color Doppler ultrasound, MRI), treatment and prognosis of the 21 cases were analyzed retrospectively.Results There were 21 cases of patients with dermatofibrosarcoma protuberans, including 9 males and 12 females.13 cases were misdiagnosed at first visit(61.90%).Surgical resection of the enlarged 3cm was performed in 21 cases,and postoperative radiotherapy was made, and the follow-up last for 1 to 5 years; 2 cases were relapsed.Conclusion Primary lesion of Dermatofibrosarcoma protuberans is a single red nodules, so it is easy to misdiagnose.However, it is not easy to transfer.Enlarge excision plus auxiliary radiotherapy in treatment are the main treatment of fibrosarcoma.
机构地区 武汉市第一医院
出处 《中国皮肤性病学杂志》 CAS CSCD 北大核心 2018年第1期38-41,共4页 The Chinese Journal of Dermatovenereology
关键词 隆突性皮肤纤维肉瘤 诊断 扩大切除 放疗 Dermatofibrosacoma protuberans Diagnosis Enlarge excision Radiation therapy
  • 相关文献

参考文献4

二级参考文献21

  • 1Kamiya T,Saga K,Kaneko R,et al.Postradiation dermatofibrosarcoma protuberans[J].Acta Derm Venereol,2006,86(2):152-153.
  • 2Sirvent N,Maire G.Genetics of dermatofibrosarcoma protuberans family of tumors:from ring chromosomes to tyrosine kinase inhibitor treatment genes[J].Chromosomes Cancer,2003,37(1):1-19.
  • 3Bandarchi B, Ma L, Marginean C, et al. D2-40, a novel immuno- histemical marker in differentiating dermatofibroma from dermato- fibrosarcoma protuberans [J].Modem pathology,2010,23(3):434-438.
  • 4Farina JM, Ammori JB, Zager JS, et al. Dermatofibrosarcoma Pro- tuberans:How Wide Should We Resect [J]? Ann Surg Oncol,2010, 17(8):2112-2118.
  • 5Nelson R A, Arlette J P. Mohs micrographie surgery and dermatofi- brosarcoma protuberans: a multidisciplinary approach in 44 pa- tients [J]. Ann PlastSurg, 2008,60(6): 667-672.
  • 6Giacchero D, Maire G, Nuin PA, et al. No correlation between the molecular subtype of COL1A1-PDGFB fusion gene and the clinico- histopathological features of dermatofibrosarcoma protuberans [J]. Invest Dermatol ,2010, 130(3):904-907.
  • 7Rutkowski P,van Glabbeke M,Rankin ej,et al.imatinib mesylate in advanced dermatofibrosarcoma protuberans pooled analysis of two phase II clinical trials [J]. Clin Oncol,2010,28(10):1772-1779.
  • 8JamesWD,BergerTG,Elaton DM. Andrews clinical dermatology[M]. 10th ed.Beijing: Science Press,2008:646.
  • 9武忠弼.中华外科学[M].北京:人民卫生出版社,2002:2238-2239.
  • 10SternbergSS.Diagnosticsurgicalpathology [M].3rd ed.Beijing: Peking University Medical Press,2003:66-67.Stemberg SS.诊断外科病理学[M],3版.北京:北京大学医学出版社,2003:66.67.

共引文献12

同被引文献38

引证文献7

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部